Aim: The aim of the present study was to clarify esophagogastric junction (EGJ) carcinoma patients who are at high risk of upper and middle mediastinal lymph node (MLN) metastasis.
| INTRODUCTION
The incidence of esophagogastric junction (EGJ) carcinoma has increased around the world, [1] [2] [3] including Japan. However, the optimal surgical treatment for EGJ carcinoma remains controversial. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] In Western countries, adenocarcinoma (AC) is the major histological type, and the Siewert classification has been adopted. 14 The surgical approach for EGJ adenocarcinoma is based on the tumor location.
Usually, a transthoracic approach is carried out for patients with Siewert type I tumors, whereas the transhiatal approach is used for those with Siewert type III tumors. Both approaches have been used for Siewert type II tumors. A Dutch trial compared the right thoracic and transhiatal approaches for Siewert tumor types I and II. 4 Although the survival rate of patients with Siewert type II tumors was not different between the groups, a subgroup analysis of nodal metastatic patients showed that survival in patients who underwent the transthoracic approach was significantly better than that of patients who underwent the transhiatal approach. 4 Squamous cell carcinoma (SCC) of the EGJ is often observed in Asian populations.
Therefore, Nishi's classification of EGJ carcinoma has been used in Japan. 15 This definition describes EGJ carcinoma as a tumor whose tumor epicenter is located within a 2-cm area above and below the EGJ, regardless of histological type. Although this classification includes both histological types, most patients with AC have received a resection of the lower esophagus and stomach, whereas those with SCC have undergone subtotal esophagectomy, reflecting differences in the dominant tumor location.
Siewert et al 16 showed that R0 resection was a prognostic factor in patients with EGJ carcinoma. Thus, appropriate prophylactic mediastinal lymph node (MLN) dissection is necessary for EGJ carcinoma.
We usually use two major surgical approaches for EGJ carcinoma to retrieve MLN: the transthoracic approach and the transhiatal approach. The transthoracic approach is a more invasive procedure, which may increase morbidity and worsen the patient's quality of life after surgery. Although lymph nodes in the lower mediastinal region can be retrieved using both approaches, lymph node dissection of the upper-middle mediastinum can only be carried out with the transthoracic approach. However, the optimal surgical approach for patients with EGJ carcinoma remains unclear. In the present study, we aimed to explore high-risk EGJ carcinoma patients who have upper and middle MLN metastasis/recurrence and underwent the transthoracic approach. We retrospectively collected the medical records of patients with EGJ carcinoma (diagnosed according to Nishi's classification 15 ) who underwent surgical resection.
| MATERIALS AND METHODS

| Patients
This was a retrospective study and included 110 consecutive patients diagnosed with EGJ carcinoma who subsequently underwent curative surgical resection at Keio University Hospital (Tokyo, Japan) between January 2000 and December 2013. In an additional study, 22 EGJ carcinoma patients who were treated with surgical resection between January 2014 and November 2016 were included to prove the suitability of our algorithm, which was created according to the results of our retrospective study. EGJ carcinoma was defined according to Nishi's classification. 15 EGJ was identified from the resected specimen and was defined using the level of macroscopic caliber change. Tumors with epicenters located in the area of the EGJ, extending from 2 cm above to 2 cm below the EGJ, were designated as EGJ carcinomas.
| Follow up
For postoperative follow up, we usually carry out computed tomography (CT) scan every 6 months and endoscopic examination every year after operation.
| Evaluation and lymph node station
The 7th edition of the Union for International Cancer Control tumornode-metastasis classification of esophageal cancer was used for tumor staging, 17 and the Japanese classification of esophageal carcinoma was used to number the lymph node stations. 15 The upper mediastinal area included the upper thoracic paraesophageal (#105) and thoracic paratracheal lymph nodes (#106). The middle mediastinal area included the subcarinal (#107), middle thoracic paraesophageal (#108), and main bronchus lymph nodes (#109). The lower mediastinal area included the lower thoracic paraesophageal (#110), supradiaphragmatic (#111), and posterior MLN (#112).
| Therapeutic value of lymph node dissection
To evaluate the therapeutic value of dissecting each lymph node sta- with AC and SCC (P = 0.222).
Metastasis to MLN was detected in seven patients with AC (8.3%) and in eleven patients with SCC (42.3%). There were no patients who had lymph node metastasis to the pyloric region. The therapeutic value of extended nodal dissection of each lymph node station is shown in Table 2 2), as shown in Table 2 .
| Recurrence patterns
Of all patients, 30.9% (34/110) developed recurrence, of whom 18 (16.4%) showed nodal recurrence in one or more regions (lymphatic recurrence: para-aortic n = 10, gastric region n = 6, mediastinal region n = 9, cervical region n = 2; hematogenous recurrence: lung n = 7, liver n = 8, bone n = 3, peritoneum n = 6).
| Mediastinal lymph node metastasis and recurrence
Mediastinal lymph node metastasis was observed in 18 patients, and the number increased to 23 when the recurrence cases were added Table 3 . Of the 23 patients, rates for MLN metastasis were significantly higher when the tumor epicenter was located above the EGJ (18/51: 35.3%), as compared to when the epicenter was located below the EGJ (5/59: 8.5%). In these patients, two pT1 cases presented MLN metastasis, and the tumor epicenter was located above the EGJ in both cases. In contrast, five patients whose tumor epicenter was located below the EGJ and who had MLN metastasis/recurrence were diagnosed with advanced carcinoma (pT2/T3/T4: 1/3/1).
Of the total of 110 patients, 12 were found to have upper-middle MLN metastasis/recurrence. In these patients, eight were AC and four were SCC, and they all had ≥pT2 tumor (pT2/T3/T4: 1/8/3). No significant difference was identified between the two histological types (Table 4) . Among all patients, MLN metastasis and recurrence rates were found to be high when the distance from the EGJ to the proximal edge of the primary tumor was >3 cm for upper and middle mediastinum (18.8%) and >2 cm for lower mediastinum (15.0%) (Table 5) .
We used multivariate analysis to identify the risk factors for two groups (selected/non-selected groups) using the algorithm, and the MLN metastasis/recurrence rates were then compared. The algorithm was not used to choose the surgical procedure, but rather as a validation check. In the additional study, 11 patients were treated by the transhiatal approach and 11 patients were treated by the transthoracic approach. Seven patients were placed in the selected group that showed significantly higher mediastinal metastasis/recurrence rates 
| DISCUSSION
In the present study, we created a surgical algorithm for the treat- Tumor epicenters for EGJ carcinomas as defined by Nishi's classification are 1 cm higher (2 cm above and 2 cm below the EGJ) than those of Siewert type II carcinomas (1 cm above and 2 cm below the EGJ).
Thus, the subgroup analysis suggested that MLN dissection using the transthoracic approach is effective in patients with EGJ carcinomas with nodal metastasis as defined by Nishi's classification.
In terms of the preoperative diagnostic accuracies of the three elements of our algorithm, we first address the location of the tumor epicenter. In five patients ultimately diagnosed with esophageal-side tumors, location of the tumor epicenters was preoperatively judged as the gastric side. However, in these cases, the tumor epicenters were located just above (0 mm from) the EGJ. Therefore, these are not actually errors, as they are related to how to define a tumor on the EGJ (esophageal or gastric). In another six (5.5%) cases, the patients were ultimately diagnosed with gastric-side tumors, although the location of of the four cases developed recurrence. However, it should be noted that these four cases were not obviously T2 tumor endoscopically.
As the first two steps of our algorithm (location of the tumor epicenter and early/advanced carcinoma) are simple, the effect of the errors on surgical decision-making was small.
Third, in terms of the preoperative length of esophageal invasion, the precise length (in cm) was not noted prior to surgery in some cases, especially older cases; the correctness (or otherwise) of length evaluation is thus unknown.
In addition, in terms of the preoperative diagnostic accuracy of MLN metastasis, six cases showed CT findings of MLN metastasis prior to surgery, of whom five were ultimately found to have mediastinal metastases. The other 13 cases showed no CT findings of MLN metastasis, but such metastases were discovered on pathological evaluation. CT sensitivity for diagnosis of MLN metastasis was 27.8% (5/18) and the specificity was 98.9% (91/92) (Table S1 ). This means that patients with enlarged lymph nodes (thus clinically positive) were at high risk of metastasis, but clinically negative cases might nonetheless have metastases. Thus, estimation of the risk of MLN metastasis by reference to tumor location and depth, and the length of esophageal invasion, is necessary.
All deaths except two were caused by the original disease.
The two exceptions were deaths caused by postoperative complications (pneumonia). One patient had an AC and the other a SCC.
The prognosis did not differ significantly between the SCC and AC groups. However, SCC was associated with a lower 3-year survival rate, and the survival curve trended downward, reflecting the histological malignancy of SCC. However, if a tumor was present in the same location, the initial lymphatic ducts invaded In addition, when we included cases showing initial MLN recurrence, we found that recurrence could be prevented by MLN dissection. Of course, the possibility that recurrence cannot be prevented must also be considered. In the future, further investigation of a greater number of cases undergoing upper and middle MLN dissection by reference to our algorithm is required. Third, the median follow-up period was 51.5 months (>3 years), but some patients with a short observation period (lost to follow up) were included. In total, 18 patients were lost to follow up over 36 months (12 cases, follow up less than 1 year; 1 case, less than 2 years; 5 cases, less than 3 years).
In conclusion, location of the tumor epicenter, depth of invasion (T factor), and extent of esophageal invasion should be considered 
